The impact of androgen receptor expression on breast cancer survival: A retrospective study and meta-analysis

PLoS ONE

Volumn 8, Issue 12, 2013, Pages

  Qu, Qing ^a   Mao, Yan ^a   Fei, Xiao Chun ^a   Shen, Kun Wei ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR; ESTROGEN RECEPTOR;

ARTICLE; BREAST CANCER; BREAST SURGERY; CANCER RECURRENCE; CANCER SURVIVAL; CHINA; DISEASE FREE SURVIVAL; ESTROGEN RECEPTOR POSITIVE BREAST CANCER; HUMAN; OVERALL SURVIVAL; PREDICTION; PROTEIN EXPRESSION; RECURRENCE RISK; RETROSPECTIVE STUDY; TRIPLE NEGATIVE BREAST CANCER;

BREAST NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; NEOPLASM STAGING; ODDS RATIO; PROGNOSIS; RECEPTORS, ANDROGEN; RETROSPECTIVE STUDIES; SURVIVORS;

EID: 84891752262     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0082650     Document Type: Article

References (25)

1. Perou CM, Sørlie T, Eisen MB, van de Rijn M, Jeffrey SS et al. (2000) Molecular portraits of human breast tumours. Nature 406: 747-752. doi:10.1038/35021093. PubMed: 10963602.
2. Early Breast Cancer Trialists' Collaborative Group (EBCTCG) (2005) Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 365: 1687-1717. doi:10.1016/S0140-6736(05)66544-0. PubMed: 15894097.
3. Tuma RS (2005) Trastuzumab trials steal show at ASCO meeting. J Natl Cancer Inst 97: 870-871. doi:10.1093/jnci/97.12.870. PubMed: 15956644.
4. Berry DA, Cronin KA, Plevritis SK, Fryback DG, Clarke L et al. (2005) Effect of screening and adjuvant therapy on mortality from breast cancer. N Engl J Med 353: 1784-1792. doi:10.1056/NEJMoa050518. PubMed: 16251534.
5. Moinfar F, Okcu M, Tsybrovskyy O, Regitnig P, Lax SF et al. (2003) Androgen receptors frequently are expressed in breast carcinomas: potential relevance to new therapeutic strategies. Cancer 98: 703-711. doi:10.1002/cncr.11532. PubMed: 12910513.
6. Kuenen-Boumeester V, Van der Kwast TH, Claassen CC, Look MP, Liem GS et al. (1996) The clinical significance of androgen receptors in breast cancer and their relation to histological and cell biological parameters. Eur J Cancer 32A: 1560-1565. PubMed: 8911118.
7. Agoff SN, Swanson PE, Linden H, Hawes SE, Lawton TJ (2003) Androgen receptor expression in estrogen receptor-negative breast cancer. Immunohistochemical, clinical, and prognostic associations. Am J Clin Pathol 120: 725-731. doi:10.1309/42F00D0DJD0J5EDT. PubMed: 14608899.
8. Schippinger W, Regitnig P, Dandachi N, Wernecke KD, Bauernhofer T et al. (2006) Evaluation of the prognostic significance of androgen receptor expression in metastatic breast cancer. Virchows Arch 449: 24-30. doi:10.1007/s00428-006- 0213-6. PubMed: 16628414.
9. Gonzalez LO, Corte MD, Vazquez J, Junquera S, Sanchez R et al. (2008) Androgen receptor expresion in breast cancer: relationship with clinicopathological characteristics of the tumors, prognosis, and expression of metalloproteases and their inhibitors. BMC Cancer 8: 149. doi:10.1186/1471-2407- 8-149. PubMed: 18507821.
10. Luo X, Shi YX, Li ZM, Jiang WQ (2010) Expression and clinical significance of androgen receptor in triple negative breast cancer. Chin J Cancer 29: 585-590. doi:10.5732/cjc.009.10673. PubMed: 20507730.
11. Castellano I, Allia E, Accortanzo V, Vandone AM, Chiusa L et al. (2010) Androgen receptor expression is a significant prognostic factor in estrogen receptor positive breast cancers. Breast Cancer Res Treat 124: 607-617. doi:10.1007/s10549-010-0761-y. PubMed: 20127405.
12. Yu Q, Niu Y, Liu N, Zhang JZ, Liu TJ et al. (2011) Expression of androgen receptor in breast cancer and its significance as a prognostic factor. Ann Oncol 22: 1288-1294. doi:10.1093/annonc/mdq586. PubMed: 21109569.
13. Park S, Koo JS, Kim MS, Park HS, Lee JS et al. (2011) Androgen receptor expression is significantly associated with better outcomes in estrogen receptor-positive breast cancers. Ann Oncol 22: 1755-1762. doi:10.1093/annonc/ mdq678. PubMed: 21310761.
14. Hu R, Dawood S, Holmes MD, Collins LC, Schnitt SJ et al. (2011) Androgen receptor expression and breast cancer survival in postmenopausal women. Clin Cancer Res 17: 1867-1874. doi:10.1158/1078-0432.CCR-10-2021. PubMed: 21325075.
15. Tang D, Xu S, Zhang Q, Zhao W (2012) The expression and clinical significance of the androgen receptor and E-cadherin in triple-negative breast cancer. Med Oncol 29: 526-533. doi:10.1007/s12032-011-9948-2. PubMed: 21519872.
16. He J, Peng R, Yuan Z, Wang S, Peng J et al. (2012) Prognostic value of androgen receptor expression in operable triple-negative breast cancer: a retrospective analysis based on a tissue microarray. Med Oncol 29: 406-410. doi:10.1007/s12032-011-9832-0. PubMed: 21264529.
17. Park S, Park HS, Koo JS, Yang WI, Kim SI et al. (2012) Higher expression of androgen receptor is a significant predictor for better endocrine- responsiveness in estrogen receptor-positive breast cancers. Breast Cancer Res Treat 133: 311-320. doi:10.1007/s10549-011-1950-z. PubMed: 22231421.
18. Ingle JN, Twito DI, Schaid DJ, Cullinan SA, Krook JE et al. (1991) Combination hormonal therapy with tamoxifen plus fluoxymesterone versus tamoxifen alone in postmenopausal women with metastatic breast cancer. An updated analysis. Cancer 67: 886-891. doi:10.1002/1097-0142(19910215)67:4. PubMed: 1991261.
19. Peters AA, Ingman WV, Tilley WD, Butler LM (2011) Differential effects of exogenous androgen and an androgen receptor antagonist in the peri- and postpubertal murine mammary gland. Endocrinology 152: 3728-3737. doi:10.1210/en.2011-1133. PubMed: 21846805.
20. Naderi A, Chia KM, Liu J (2011) Synergy between inhibitors of androgen receptor and MEK has therapeutic implications in estrogen receptor-negative breast cancer. Breast Cancer Res 13: R36. doi:10.1186/bcr2858. PubMed: 21457548.
21. Søiland H, Kørner H, Skaland I, Janssen EA, Gudlaugsson E et al. (2008) Prognostic relevance of androgen receptor detection in operable breast cancer. J Surg Oncol 98: 551-558. doi:10.1002/jso.21156. PubMed: 18937259.
22. Peters KM, Edwards SL, Nair SS, French JD, Bailey PJ et al. (2012) Androgen receptor expression predicts breast cancer survival: the role of genetic and epigenetic events. BMC Cancer 12: 132. doi:10.1186/1471-2407-12-132. PubMed: 22471922.
23. Mrklić I, Pogorelić Z, Capkun V, Tomić S (2013) Expression of androgen receptors in triple negative breast carcinomas. Acta Histochem 115: 344-348. doi:10.1016/j.acthis.2012.09.006. PubMed: 23031358.
24. Loibl S, Müller BM, von Minckwitz G, Schwabe M, Roller M et al. (2011) Androgen receptor expression in primary breast cancer and its predictive and prognostic value in patients treated with neoadjuvant chemotherapy. Breast Cancer Res Treat 130: 477-487. doi:10.1007/s10549-011-1715-8. PubMed: 21837479.
25. Agrawal AK, Jeleń M, Grzebieniak Z, Zukrowski P, Rudnicki J et al. (2008) Androgen receptors as a prognostic and predictive factor in breast cancer. Folia Histochem Cytobiol 46: 269-276. PubMed: 19056529.